Search Results

There are 12567 results for: content related to: A Dose-Ranging Study of Azathioprine Pharmacokinetics After Single-Dose Administration of a Delayed-Release Oral Formulation

  1. You have free access to this content
    A dose-ranging pharmacokinetic study of nicotine tartrate following single-dose delayed-release oral and intravenous administration

    Alimentary Pharmacology & Therapeutics

    Volume 11, Issue 5, October 1997, Pages: 865–874, R. F. COMPTON, W. J. SANDBORN, G. M. LAWSON, A. J. SHEETS, D. C. MAYS, B. J. ZINS, W. J. TREMAINE, J. J. LIPSKY, D. W. MAHONEY, A. R. ZINSMEISTER, K. P. OFFORD, R. D. HURT, B. K. EVANS and J. GREEN

    Version of Record online : 2 OCT 2003, DOI: 10.1046/j.1365-2036.1997.00236.x

  2. Review of the New Delayed-Release Oral Tablet and Intravenous Dosage Forms of Posaconazole

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 35, Issue 2, February 2015, Pages: 208–219, Anthony J. Guarascio and Douglas Slain

    Version of Record online : 3 FEB 2015, DOI: 10.1002/phar.1533

  3. You have free access to this content
    Randomised clinical trial: delayed-release oral mesalazine 4.8 g/day vs. 2.4 g/day in endoscopic mucosal healing – ASCEND I and II combined analysis

    Alimentary Pharmacology & Therapeutics

    Volume 33, Issue 6, March 2011, Pages: 672–678, G. R. Lichtenstein, D. Ramsey and D. T. Rubin

    Version of Record online : 23 JAN 2011, DOI: 10.1111/j.1365-2036.2010.04575.x

  4. Design of tablets for the delayed and complete release of poorly water-soluble weak base drugs using SBE7M-β-CD as a solubilizing agent

    Journal of Pharmaceutical Sciences

    Volume 100, Issue 4, April 2011, Pages: 1576–1587, Venkatramana M. Rao, Erika A. Zannou and Valentino J. Stella

    Version of Record online : 1 DEC 2010, DOI: 10.1002/jps.22375

  5. You have free access to this content
    The effect of mesalazine therapy on quality of life in patients with mildly and moderately active ulcerative colitis

    Alimentary Pharmacology & Therapeutics

    Volume 28, Issue 11-12, December 2008, Pages: 1278–1286, E. J. IRVINE, C.-H. YEH, D. RAMSEY, A. L. STIRLING and P. D. R. HIGGINS

    Version of Record online : 19 SEP 2008, DOI: 10.1111/j.1365-2036.2008.03854.x

  6. Abstracts from the 2008 Advances in Inflammatory Bowel Diseases, Crohn's & Colitis Foundation's National Clinical & Research Conference

    Inflammatory Bowel Diseases

    Volume 14, Issue S3, December 2008, Pages: S1–S49,

    Version of Record online : 26 NOV 2008, DOI: 10.1002/ibd.20829

  7. Controlled-Release Dosage Forms

    Pharmaceutical Manufacturing Handbook: Production and Processes

    Shayne Cox Gad, Pages: 345–392, 2007

    Published Online : 28 AUG 2007, DOI: 10.1002/9780470259818.ch11

  8. Systemic Drugs

    Canine and Feline Dermatology Drug Handbook

    Sandra N. Koch, Sheila M.F. Torres, Donald C. Plumb, Pages: 1–218, 2013

    Published Online : 28 MAR 2013, DOI: 10.1002/9781118704745.ch1

  9. Exploring the controversial themes of IBD

    Inflammatory Bowel Diseases

    Volume 15, Issue S1, September 2009, Pages: S1–S10, Stephen B. Hanauer

    Version of Record online : 19 AUG 2009, DOI: 10.1002/ibd.20945

  10. Design and In Vivo Anti-Inflammatory Effect of Ketoprofen Delayed Delivery Systems

    Journal of Pharmaceutical Sciences

    Volume 104, Issue 10, October 2015, Pages: 3451–3458, Andrea Cerciello, Giulia Auriemma, Silvana Morello, Aldo Pinto, Pasquale Del Gaudio, Paola Russo and Rita P. Aquino

    Version of Record online : 18 JUN 2015, DOI: 10.1002/jps.24554

  11. After the randomised injectable opiate treatment trial: Post-trial investigation of slow-release oral morphine as an alternative opiate maintenance medication

    Drug and Alcohol Review

    Volume 31, Issue 4, June 2012, Pages: 492–498, ALYSON J. BOND, KYLIE D. REED, PETE BEAVAN and JOHN STRANG

    Version of Record online : 15 SEP 2011, DOI: 10.1111/j.1465-3362.2011.00353.x

  12. You have free access to this content
    The United States experience with oral controlled-release morphine (MS contin tablets).parts i and ii. review of nine dose titration studies and clinical pharmacology of 15-mg, 30-mg, 60-mg, and 100-mg tablet strengths in normal subjects

    Cancer

    Volume 63, Issue 11, 1 June 1989, Pages: 2348–2354, Robert F. Kaiko, Robert P. Grandy, Benjamin Oshlack, Joseph Pav, Joseph Horodniak, Gordon Thomas, Ellen Ingber and Paul D. Goldenheim

    Version of Record online : 29 JUN 2006, DOI: 10.1002/1097-0142(19890601)63:11<2348::AID-CNCR2820631146>3.0.CO;2-V

  13. You have free access to this content
    DRIVING CAPACITY OF PATIENTS TREATED WITH METHADONE AND SLOW-RELEASE ORAL MORPHINE

    Addiction

    Volume 100, Issue 7, July 2005, Page: 1027, S. M. GIACOMUZZI, M. ERTL, A. VIGL, Y. RIEMER, V. GÜNTHER, M. KOPP, W. PILSZ and W. HAASER

    Version of Record online : 14 JUN 2005, DOI: 10.1111/j.1360-0443.2005.01148.x

  14. Dissolution testing of oral modified-release dosage forms

    Journal of Pharmacy and Pharmacology

    Volume 64, Issue 7, July 2012, Pages: 944–968, Grzegorz Garbacz and Sandra Klein

    Version of Record online : 21 FEB 2012, DOI: 10.1111/j.2042-7158.2012.01477.x

  15. You have full text access to this OnlineOpen article
    Effects of food on pharmacokinetics of immediate release oral formulations of aspirin, dipyrone, paracetamol and NSAIDs – a systematic review

    British Journal of Clinical Pharmacology

    Volume 80, Issue 3, September 2015, Pages: 381–388, Robert Andrew Moore, Sheena Derry, Philip J. Wiffen and Sebastian Straube

    Version of Record online : 6 JUL 2015, DOI: 10.1111/bcp.12628

  16. 5-aminosalicylates

    Pocket Guide to Gastrointestinal Drugs

    Hannah L. Miller, Francis A. Farraye, Pages: 82–99, 2014

    Published Online : 10 JAN 2014, DOI: 10.1002/9781118481530.ch6

  17. You have free access to this content
    Naturalistic exploration of the effect of osmotic release oral system-methylphenidate on remission rate and functional improvement in Taiwanese children with attention-deficit–hyperactivity disorder

    Psychiatry and Clinical Neurosciences

    Volume 66, Issue 1, February 2012, Pages: 53–63, Ruu-Fen Tzang, Ya-Ching Wang, Chin-Bin Yeh, Cheng-Dien Hsu, Hsin-Yi Liang, Pin-Chen Yang, Hung-Jen Liu, Yu-Shu Huang, Helen Cheng, Ya-Chen Hsu, Shen-Ing Liu, Chia-Ho Pan, Ya-Fen Huang, Chi-Fen Huang, Yu-Yu Wu, Yu-Hsin Huang, Hui-Ching Liu and Hsueh-Ling Chang

    Version of Record online : 18 JAN 2012, DOI: 10.1111/j.1440-1819.2011.02289.x

  18. You have free access to this content
    Slow-release oral morphine for opioid maintenance treatment: a systematic review

    British Journal of Clinical Pharmacology

    Volume 71, Issue 6, June 2011, Pages: 832–843, Jeremie Jegu, Adeline Gallini, Pauline Soler, Jean-Louis Montastruc and Maryse Lapeyre-Mestre

    Version of Record online : 12 MAY 2011, DOI: 10.1111/j.1365-2125.2011.03923.x

  19. You have free access to this content
    Paper Poster Sessions

    European Journal of Neurology

    Volume 21, Issue s1, May 2014, Pages: 388–713,

    Version of Record online : 28 MAY 2014, DOI: 10.1111/ene.12497

  20. Acute kidney injury is common with intravenous abuse of extended-release oral oxymorphone and delayed renal recovery rates are associated with increased KDIGO staging

    Nephrology

    Accepted manuscript online: 12 AUG 2017, Alex K. Bonnecaze, Matthew Whitaker Wilson, Ajay Dharod, Alison Fletcher and PJ Miller

    DOI: 10.1111/nep.13153